Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
26 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 Feb 24
8-K
Other Events
14 Feb 24
8-K
Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program
8 Feb 24
8-K
Changes in Registrant's Certifying Accountant
5 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
6 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Nov 23
8-K
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
15 Nov 23
8-K
Yield10 Bioscience Announces Third Quarter 2023 Financial Results
14 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land
31 Oct 23
8-K
Other Events
19 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Sep 23
8-K
Other Events
11 Sep 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Yield10 Bioscience Announces Second Quarter 2023 Financial Results
14 Aug 23
8-K
Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering
11 Aug 23
424B4
Prospectus supplement with pricing info
11 Aug 23
EFFECT
Notice of effectiveness
11 Aug 23
CORRESP
Correspondence with SEC
8 Aug 23
CORRESP
Correspondence with SEC
7 Aug 23
8-K
Other Events
2 Aug 23
S-1/A
IPO registration (amended)
2 Aug 23
UPLOAD
Letter from SEC
21 Jul 23
424B3
Prospectus supplement
18 Jul 23
EFFECT
Notice of effectiveness
17 Jul 23
S-1
IPO registration
13 Jul 23
CORRESP
Correspondence with SEC
12 Jul 23
S-1/A
IPO registration (amended)
12 Jul 23
UPLOAD
Letter from SEC
10 Jul 23
S-1
IPO registration
30 Jun 23
S-8
Registration of securities for employees
14 Jun 23
8-K
Departure of Directors or Certain Officers
30 May 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 May 23
10-Q
2023 Q1
Quarterly report
12 May 23
8-K
Yield10 Bioscience Announces First Quarter 2023 Financial Results
10 May 23
424B5
Prospectus supplement for primary offering
4 May 23
8-K
Yield10 Bioscience Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement
4 May 23
8-K
Termination of a Material Definitive Agreement
3 May 23
8-K
Entry into a Material Definitive Agreement
1 May 23
Latest ownership filings
4
Kristi Snell
20 Feb 24
4
CHARLES B HAASER
16 Feb 24
4
Oliver P Peoples
16 Feb 24
4
LYNNE H BRUM
16 Feb 24
4
NOSTRAND ROBERT L VAN
3 Jan 24
4
Richard William Hamilton
3 Jan 24
4
Anthony J Sinskey
3 Jan 24
4
JACK W SCHULER
20 Dec 23
4
JACK W SCHULER
11 Dec 23
SC 13D
SCHULER JACK W
11 Oct 23
4
JACK W SCHULER
10 Oct 23
4
JACK W SCHULER
6 Oct 23
4
Anthony J Sinskey
2 Oct 23
4
NOSTRAND ROBERT L VAN
2 Oct 23
4
Richard William Hamilton
2 Oct 23
4
NOSTRAND ROBERT L VAN
5 Jul 23
4
Richard William Hamilton
5 Jul 23
4
Anthony J Sinskey
5 Jul 23
4
Sherri M. Brown
30 May 23
4
Richard William Hamilton
30 May 23
4
WILLIE LOH
30 May 23
4
Anthony J Sinskey
30 May 23
4
NOSTRAND ROBERT L VAN
30 May 23
SC 13D/A
SCHULER JACK W
26 May 23
4
JACK W SCHULER
9 May 23
4
JACK W SCHULER
9 May 23
4
JACK W SCHULER
9 May 23
4
Anthony J Sinskey
4 Apr 23
4
NOSTRAND ROBERT L VAN
4 Apr 23
4
Richard William Hamilton
4 Apr 23
4
Oliver P Peoples
14 Feb 23
4
LYNNE H BRUM
14 Feb 23
4
Kristi Snell
14 Feb 23
4
CHARLES B HAASER
14 Feb 23
4
CHARLES B HAASER
13 Jan 23
4
LYNNE H BRUM
13 Jan 23
4
Kristi Snell
13 Jan 23
4
Oliver P Peoples
13 Jan 23
4
NOSTRAND ROBERT L VAN
4 Jan 23
4
Anthony J Sinskey
4 Jan 23